In this upcoming roundtable discussion, panelists will discuss the role of eCOA and eConsent in clinical trials. These connected capabilities can offer value in terms of enhanced data and quality, but they are not without their challenges. Join us for a fantastic discussion around the current landscape of these tools and a look towards the future.
Related Posts
Takeda, Protagonist Partner to Advance Late-Stage Polycythemia Vera Drug
Image credit: Dr_Microbe | stock.adobe.com Takeda and Protagonist Therapeutics have entered a global license and collaboration agreement to develop and…
Long-Term Treatment with Kesimpta Shows Sustained Efficacy in Recently Diagnosed, Treatment-Naïve Patients with Relapsing MS
Image credit: Nathan Devery com | stock.adobe.com Results from the open-label ALITHIOS extension study demonstrated the long-term efficacy of first-line,…
Alexion’s Dual-Binding Nanobody Demonstrates Statistically Significant Improvements in Generalized Myasthenia Gravis
Image Credit: Adobe Stock Images/Robin Key Takeaways Gefurulimab shows promise in generalized myasthenia gravis (gMG) treatment: Phase III PREVAIL trial…